Your browser doesn't support javascript.
loading
Parkinson's disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration.
Carola, G; Malagarriga, D; Calatayud, C; Pons-Espinal, M; Blasco-Agell, L; Richaud-Patin, Y; Fernandez-Carasa, I; Baruffi, V; Beltramone, S; Molina, E; Dell'Era, P; Toledo-Aral, J J; Tolosa, E; Muotri, A R; Garcia Ojalvo, J; Soriano, J; Raya, A; Consiglio, A.
Afiliación
  • Carola G; Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
  • Malagarriga D; Institute of Biomedicine (IBUB) of the University of Barcelona (UB), Barcelona, Spain.
  • Calatayud C; Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
  • Pons-Espinal M; Institute of Biomedicine (IBUB) of the University of Barcelona (UB), Barcelona, Spain.
  • Blasco-Agell L; Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
  • Richaud-Patin Y; Institute of Biomedicine (IBUB) of the University of Barcelona (UB), Barcelona, Spain.
  • Fernandez-Carasa I; Regenerative Medicine Program, Bellvitge Biomedical Research Institute (IDIBELL), and Program for Clinical Translation of Regenerative Medicine in Catalonia (P-CMRC), Hospital Duran i Reynals, Barcelona, Spain.
  • Baruffi V; Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
  • Beltramone S; Institute of Biomedicine (IBUB) of the University of Barcelona (UB), Barcelona, Spain.
  • Molina E; Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
  • Dell'Era P; Institute of Biomedicine (IBUB) of the University of Barcelona (UB), Barcelona, Spain.
  • Toledo-Aral JJ; Regenerative Medicine Program, Bellvitge Biomedical Research Institute (IDIBELL), and Program for Clinical Translation of Regenerative Medicine in Catalonia (P-CMRC), Hospital Duran i Reynals, Barcelona, Spain.
  • Tolosa E; Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
  • Muotri AR; Institute of Biomedicine (IBUB) of the University of Barcelona (UB), Barcelona, Spain.
  • Garcia Ojalvo J; Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
  • Soriano J; Institute of Biomedicine (IBUB) of the University of Barcelona (UB), Barcelona, Spain.
  • Raya A; Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
  • Consiglio A; Institute of Biomedicine (IBUB) of the University of Barcelona (UB), Barcelona, Spain.
NPJ Parkinsons Dis ; 7(1): 55, 2021 Jul 02.
Article en En | MEDLINE | ID: mdl-34215735

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Parkinsons Dis Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Parkinsons Dis Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos